Dabigatran Etexilate and Von willebrand factor recombinant Intravenous
Determining the interaction of Dabigatran Etexilate and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabigatran
Brand name: Pradaxa
Synonyms: Dabigatran
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabigatran Etexilate-Vonvendi
- Dabigatran Etexilate-Vopac
- Dabigatran Etexilate-Vopac MDS
- Dabigatran Etexilate-Vorapaxar
- Dabigatran Etexilate-Vorapaxar Sulfate
- Dabigatran Etexilate-Voraxaze
- Von willebrand factor recombinant Intravenous-Dabigatran Etexilate Mesylate
- Von willebrand factor recombinant Intravenous-Dabrafenib
- Von willebrand factor recombinant Intravenous-Dabrafenib Mesylate
- Von willebrand factor recombinant Intravenous-Dacarbazine
- Von willebrand factor recombinant Intravenous-Dacarbazine Intravenous, Injection
- Von willebrand factor recombinant Intravenous-Daclatasvir